NICE releases draft guidance for using cannabis-based medicinal products
The NICE and NHS have announced their draft recommendations for the prescribed use of cannabis-based treatments.
List view / Grid view
News
FDA antibody biosimilar product approvals increase in 2019
2019 has seen a marked increase of antibody biosimilar product approvals in the first half of the year, according to a report.
Increasing number of diseases causing alopecia boosts treatment market
The global alopecia treatment market is projected to exhibit a CAGR of 4.9 percent from 2018–2026.
Thermally-stable TB vaccine developed using new technique
A new process developed by the University of Bath protects a TB antigen and a novel vaccine adjuvant from heat damage.
Pharma contract placements found to increase 250 percent
Pharma contract placement was found to increase by 250 percent compared to last year, according to figures from a recruitment firm.
Novartis could face legal action over Zolgensma application
The pharmaceutical company failed to inform the FDA of manipulated data when the gene therapy was under review and could face a legal battle.
UK pharma reputation falls due to Brexit and other factors
Less than one-third of UK patient groups rate the reputation of the pharma industry as good or excellent.
Major step towards Candida auris vaccine developed
Researchers have detailed recent breakthrough experiments that successfully immunised mice against the Candida auris infection.
Philippines may re-introduce controversial dengue vaccine
The Philippines is considering re-introducing a dengue vaccine whose use was ceased because of links to several deaths.
Liposomal medicine names to be changed to avoid errors
The EMA has requested that liposomal medication names be changed to avoid the risk of confusion.
US and China should collaborate more to bring AI to healthcare
New article says that to take full advantage of deep-learning solutions in healthcare, the US and China should collaborate, not compete.
Metastatic melanoma treatment gets Breakthrough Therapy Designation
Breakthrough Therapy Designation has been granted for investigational agent bempegaldesleukin in combination with nivolumab.
Pharmaceutical chemical market to witness significant growth
The rise of manufacturing advanced drugs will stimulate growth in the pharmaceutical chemical market.
Swine fever in China raises concern over heparin supply for US
The US supply of heparin, an ingredient used in anticoagulant drugs and found in pigs, is under threat due to an outbreak of disease in Chinese herds.
NICE recommends Lokelma treatment for hyperkalaemia
Lokelma, a treatment for hyperkalaemia in adults, has received a positive Final Appraisal Document from NICE after successful trials.
